zearalenone and Polycystic-Ovary-Syndrome

zearalenone has been researched along with Polycystic-Ovary-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for zearalenone and Polycystic-Ovary-Syndrome

ArticleYear
Molecular and biochemical evidence on the role of zearalenone in rat polycystic ovary.
    Toxicon : official journal of the International Society on Toxinology, 2018, Volume: 154

    Globally, food and animal feed contamination with mycotoxins is one of the most important challenges affecting human health. Zearalenone is a non-steroidal mycotoxin with estrogen-like activity that has been reported to induce reproductive dysfunctions including polycystic ovary in women. The aim of this study was to assess the possible impact of prolonged low dose zearalenone (0.1 mg/kg b.w.) exposure to increase the risk of developing polycystic ovary in rats. We found that zearalenone increases the plasma insulin, glucose, testosterone, progesterone and luteinizing hormone levels, while the plasma estradiol level was reduced. Zearalenone also incited tumor necrosis factor-α and the secreted frizzled-related protein-4 expressions. Histological examination showed atresia of follicles in the treated group. It is concluded that zearalenone intoxication intensely manipulates the plasma hormonal factors and the level of gene expressions related to the polycystic ovary in rats, thus increases the risk of its progression.

    Topics: Animals; Blood Glucose; Estradiol; Estrogens; Female; Insulin; Luteinizing Hormone; Ovarian Follicle; Polycystic Ovary Syndrome; Progesterone; Proto-Oncogene Proteins; Random Allocation; Rats; Testosterone; Toxicity Tests, Chronic; Tumor Necrosis Factor-alpha; Zearalenone

2018